Ticker Details
Vanda Pharmaceuticals Inc. Vanda Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.
IPO Date:	April 12, 2006
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$383.66M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 2.86%
Avg Daily Range (30 D):	$0.17 | 2.77%
Avg Daily Range (90 D):	$0.22 | 3.05%

Institutional Daily Volume
Avg Daily Volume:	.61M
Avg Daily Volume (30 D):	.74M
Avg Daily Volume (90 D):	1.12M

Trade Size
Avg Trade Size (Sh.):	140
Avg Trade Size (Sh.) (30 D):	86
Avg Trade Size (Sh.) (90 D):	92

Institutional Trades
Total Institutional Trades:	3,251
Avg Institutional Trade:	$1.48M
Avg Institutional Trade (30 D):	$.97M
Avg Institutional Trade (90 D):	$1.19M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.53M
Avg Closing Trade (30 D):	$1.01M
Avg Closing Trade (90 D):	$1.12M
Avg Closing Volume:	123.04K

News

Dec 31, 2025 @ 9:09 AM Stock Market Today: S&P 500, Dow Jones Futures Dow... Source: Vishaal Sanjay

Oct 27, 2025 @ 5:00 PM Gastroparesis Market Poised for Extraordinary Grow... Source: Delveinsight

Aug 1, 2025 @ 8:18 AM Vanda (VNDA) Q2 Revenue Rises 4% Source: Jesterai

Oct 9, 2024 @ 5:00 PM Schizophrenia Clinical Trial Pipeline Insights Fea... Source: Delveinsight

Jun 7, 2024 @ 10:02 AM Vanda (VNDA) Surges 24.2%: Is This an Indication o... Source: Zacks Equity Research

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-4.05	$-.82	$-2.39
Diluted EPS	$-4.05	$-.82	$-2.39
Revenue	$217.78M	$51.72M	$57.22M
Gross Profit
Net Income / Loss	$-239.55M	$-48.57M	$-141.19M
Operating Income / Loss	$-160.36M	$-50.22M	$-40.35M
Cost of Revenue
Net Cash Flow	$-57.76M	$-30.82M	$14.83M
PE Ratio